Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

sxRNA Technologies Inc (AKA: sxRNATech)
Profile last edited on: 9/16/25      CAGE: 7YKD1      UEI: HSBFDJPP3LN7

Business Identifier: Novel RNA regulatory mechanisms: building RNA "switches" for targeting harmful cells potentially useful in diverse applications eg vaccine production.
Year Founded
2017
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

257 Fuller Road
Albany, NY 12203
   (518) 225-2036
   N/A
   www.sxrna.com
Location: Single
Congr. District: 20
County: Albany

Public Profile

An UAlbany spinoff company, sxRNA Technologies Inc. (sxRNA Tech) is a biomedical company developing novel RNA regulatory mechanisms.Specialize in building ribonucleic acid (RNA) “switches,” /structurally interacting RNAs (sxRNA). These molecular tools used for targeting and eliminating harmful cells that cause diseases. While focus is on aging brain cells,technology has potential applications for any cell type, including vaccine producti

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$500,000
Phase II Dollars
$0
Total Awarded
$500,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 1 NIH $500,000
Project Title: Creating an sxRNA Organoid Product for Advancing the Study, Prevention and Treatment of Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD)

Key People / Management

  Scott Tenenbaum

Company News

There are no news available.